EOLS
EOLS
NASDAQ · Pharmaceuticals

Evolus Inc

$7.86
-0.15 (-1.87%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 11 85%
Hold 2 15%
Sell 0 0%
Price Target
Analyst Price Target +552.5% upside
Low Target $37.24
Average Target $51.29
High Target $70.77
Current Price $7.86
Current
$7.86
Target
$51.29
$37.24 $51.29 avg $70.77
Scenario Analysis
Bear Case
$37.24
373.8%
Low target
Base Case
$51.29
+552.5%
Avg target
Bull Case
$70.77
+800.4%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$9.31
-15.6% from high
52-Week Low
$3.86
+103.6% from low
Target vs 52W High
$51.29
+450.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%